4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0000899243-22-021645
Options or other derivatives
- Director acquired 30,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ros Matthew Director | 2022-06-07 | Grant or award · Stock Option (Right to Buy) | +30,700 | 30,700 | D | ||
Loading xslF345X03/doc4.xml…